Drug Profile
Methotrexate hyaluronan complex
Alternative Names: HyMEXLatest Information Update: 20 Apr 2010
Price :
$50
*
At a glance
- Originator Meditech Research
- Class Antineoplastics
- Mechanism of Action Tetrahydrofolate dehydrogenase inhibitors; Thymidylate synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 20 Apr 2010 Discontinued - Preclinical for Cancer in Australia (unspecified route)
- 15 Aug 2003 Preclinical trials in Cancer in Australia (unspecified route)